中国实用外科杂志 ›› 2022, Vol. 42 ›› Issue (12): 1416-1420.DOI: 10.19538/j.cjps.issn1005-2208.2022.12.14

• 讲座 • 上一篇    下一篇

肝切除术式合理决策要点

李    斌,姜小清   

  1. 海军军医大学第三附属医院(上海东方肝胆外科医院)胆道一科,上海200438
  • 出版日期:2022-12-01 发布日期:2022-12-27

  • Online:2022-12-01 Published:2022-12-27

摘要: 切除病变肝组织是肝胆疾病有效的治疗手段,合理肝切除方案需要在彻底切除病灶、确保手术安全和病人最优预后等关键性治疗目标间取得平衡。肝胆恶性肿瘤肝切除术的决策要点在于合理的肝切除范围、肿瘤切缘以及对肝脏储备功能的准确评估。研究结果表明,肿瘤生物学异质性、肝段间血管交通支或流域重合的存在、肿瘤微环境新生血管等多个因素的影响可能会弱化肝细胞癌实施解剖性肝切除的治疗效应,而手术宽切缘是肝细胞癌预后获益的独立显著性因素;淋巴结转移是肿块型肝内胆管癌决策合理切缘的重要考量因素;除肿瘤累及右肝门者,扩大肝切除范围对pT2期及以上的胆囊癌并无生存优势;R1-vas切缘对肝细胞癌和结直肠癌肝转移以及肝门部胆管癌侵及肝动脉的治疗价值,值得更多探索性研究。基于保留更多功能性肝实质的理念,联合肝静脉主干切除的限制性肝切除对生长于第二肝门、肝静脉主干受侵的肝细胞癌,以及围肝门切除对于Bismuth-Corlette Ⅲ~Ⅳ型肝门部胆管癌,具有临床价值。

关键词: 肝切除, 肝胆恶性肿瘤, 肿瘤生物学行为, 手术切缘, 肝储备功能

Abstract: Reasonable decision points for hepatectomy        LI Bin,JIANG Xiao-qing. Biliary Tract Surgery Department I, Eastern Hepatobiliary Surgery Hospital,Naval Military Medical University,Shanghai 200438,China 
Corresponding author:JIANG Xiao-qing,E-mail:jxq1225@ sina.com 
Abstract    Removal of diseased liver tissue is an effective treatment for the hepatobiliary disease, and a rational hepatectomy scheme needs to balance the key therapeutic goals of complete resection of the lesion, ensuring surgical safety and optimal patient prognosis. The decision to perform hepatectomy for malignant tumours of the hepatobiliary is based on the appropriate extent of hepatic resection, tumour margins, and an accurate assessment of liver reserve function. Studies have shown that the effects of several factors, including tumour biological heterogeneity, the presence of vascular traffic branches or regional overlap in blood flow distribution between liver segments, and neovascularisation of the tumour microenvironment, may weaken the therapeutic effect of performing anatomical liver resection in hepatocellular carcinoma, and that wide resection margin is an independently significant factor in the prognostic benefit of hepatocellular carcinoma. Lymph node metastasis is an important consideration in deciding the appropriate margins for mass-forming intrahepatic cholangiocarcinoma. Except for tumour involvement of the right hepatic hilum, there is no survival advantage of expanding the scope of hepatectomy for gallbladder cancer at the pT2 stage and beyond. The therapeutic value of R1-vas incision margins for hepatocellular carcinoma and colorectal liver metastases and for perihilar cholangiocarcinoma invading the hepatic artery warrants more exploratory studies. Based on the concept of preserving a more functional liver parenchyma, restrictive hepatectomy in combination with hepatic vein trunk resection is clinically valuable for hepatocellular carcinoma growing in the secondary porta of liver with the invasion of the hepatic vein trunk, and perihepatic portal surgery for Bismuth-Corlette type III-IV perihilar cholangiocarcinoma.

Key words: hepatectomy, hepatobiliary malignancy, tumour biology, surgical margin, liver reserve function